A Major Medical Group is Shifting Stance on Gender-Affirming Surgery for Minors, Sparking Debate!
This is a significant development in the ongoing, often contentious, conversation surrounding gender-affirming care for young people. The American Society of Plastic Surgeons (ASPS), the largest professional organization for plastic surgeons in the United States, has recently recommended that gender-affirming surgeries for individuals experiencing gender dysphoria should be postponed until they reach the age of 19. This recommendation marks a notable shift for the organization and places it at odds with the guidance of several other prominent medical bodies.
The ASPS stated that they found “insufficient evidence” to support the notion that the advantages of chest, genital, and facial surgeries on minors experiencing gender dysphoria outweigh the potential risks. Their position appears to be influenced by two recent, and indeed heavily debated, publications: the Cass Review, conducted by a senior doctor in England, and a 2025 report from the U.S. Department of Health and Human Services.
It's important to note what the ASPS is saying. Their position statement clarifies that this new recommendation is not an attempt to dismiss or downplay the very real distress that patients experience, nor does it question the authenticity of their personal journeys. Instead, the ASPS emphasizes that providing truly compassionate, ethical, and just care, especially for children and adolescents, requires a careful balance between empathy, scientific evidence, developmental considerations, and a deep concern for their long-term well-being.
But here's where it gets controversial... The ASPS also pointed out that this statement is not a formal clinical guideline. They haven't conducted their own independent assessment of the evidence or taken the usual steps involved in establishing new care protocols. This distinction is crucial, as it suggests this is more of a recommendation or a statement of opinion rather than a binding directive.
Meanwhile, Other Medical Giants Stand Firm!
This shift from the ASPS occurs amidst a backdrop of increasing pressure from the Trump administration to limit or halt gender-affirming care for transgender individuals, particularly minors. A statement from Deputy Health and Human Services Secretary Jim O’Neill declared this a “victory for biological truth” and suggested the ASPS had set a new standard for other provider groups.
However, other major medical associations are sticking to their guns. They point out that their existing guidelines already advocate for a cautious approach when it comes to surgical interventions for minors. Research indicates that gender-affirming surgery is actually quite rare among children in the U.S., and even fewer adolescents receive gender-affirming medications.
Dr. Andrew Racine, president of the American Academy of Pediatrics, stated that the AAP “does not include a blanket recommendation for surgery for minors” and continues to believe that patients, their families, and their physicians—not politicians—should be the ones making these critical care decisions together.
Similarly, the World Professional Association for Transgender Health (WPATH), which sets global standards of care, reiterated its support for access to surgical care for minors, provided it's done under “cautious guidelines and criteria.” WPATH’s guidelines explicitly oppose a rigid “one-size-fits-all” approach and stress that decisions should be made on a case-by-case basis, involving a multidisciplinary team of experts in health and adolescent development.
And this is the part most people miss... The ASPS also acknowledged that the “variability in regulatory and legal environments” played a role in their decision to issue this statement. They suggested that the perceived lack of robust evidence on the benefits of gender-affirming care means that “surgical decision-making carries heightened ethical, clinical and legal risk.” Dr. Scot Glasberg, who helped craft the statement, insisted that the deliberations were not politically influenced and were an “iterative process that took time, with no outside pressure.”
What do you think? Does the ASPS's recommendation reflect a necessary scientific and ethical caution, or does it overstep by potentially limiting access to care for those who need it? Share your thoughts in the comments below – we’d love to hear your perspective!
